IND application filed for MP0712, the Company’s lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images ...
Cannae’s Reactive Actions Do Not Go Far Enough to Address Substantial Corporate Governance and Shareholder Accountability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback